Startseite Medizin Uncertainty in measurement for 43 biochemistry, immunoassay, and hemostasis routine analytes evaluated by a method using only external quality assessment data
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Uncertainty in measurement for 43 biochemistry, immunoassay, and hemostasis routine analytes evaluated by a method using only external quality assessment data

  • Gladys Matar EMAIL logo , Bernard Poggi , Roland Meley , Chantal Bon , Laurence Chardon , Karim Chikh , Anne-Claude Renard , Catherine Sotta , Jean-Christophe Eynard , Regine Cartier und Richard Cohen
Veröffentlicht/Copyright: 26. März 2015
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: International organizations require from medical laboratories a quantitative statement of the uncertainty in measurement (UM) to help interpret patient results. The French accreditation body (COFRAC) recommends an approach (SH GTA 14 IQC/EQA method) using both internal quality control (IQC) and external quality assessment (EQA) data. The aim of this work was to validate an alternative way to quantify UM using only EQA results without any need for IQC data. This simple and practical method, which has already been described as the long-term evaluation of the UM (LTUM), is based on linear regression between data obtained by participants in EQA schemes and target values. We used it for 43 routine analytes covering biochemistry, immunoassay, and hemostasis fields.

Methods: Data from 50 laboratories participating in ProBioQual (PBQ) EQA schemes over 25 months were used to obtain estimates of the median and 90th percentile LTUM and to compare them to the usual analytical goals. Then, the two UM estimation methods were compared using data from 20 laboratories participating in both IQC and EQA schemes.

Results: Median LTUMs ranged from 2.9% (sodium) to 16.3% (bicarbonates) for biochemistry analytes, from 12.6% (prothrombin time) to 18.4% (factor V) for hemostasis analytes when using the mean of all participants, and were around 10% for immunoassays when using the peer-group mean. Median LTUMs were, in most cases, slightly lower than those obtained with the SH GTA 14 method, whatever the concentration level.

Conclusions: LTUM is a simple and convenient method that gives UM estimates that are reliable and comparable to those of recommended methods. Therefore, proficiency testing (PT) organizers are allowed to provide participants with an additional UM estimate using only EQA data and which could be updated at the end of each survey.


Corresponding author: Gladys Matar, ProBioQual, 9 rue Professeur Florence 69003, Lyon, France, E-mail:

References

1. Guidelines for evaluating and expressing the uncertainty of NIST measurement results. NIST Technical Note 1994:1297.Suche in Google Scholar

2. White GH, Farrance I. Uncertainty of measurement in quantitative medical testing a laboratory implementation guide. AACB Clin Biochem Rev 2004;25(Suppl):S124.Suche in Google Scholar

3. Fuentes AX. Uncertainty of measurement in clinical microbiology. In: eJIFCC 2004;13. Available from: http://www.ifcc.org/ifccfiles/docs/130401006.pdf. Accessed November 2004.Suche in Google Scholar

4. International Laboratory Accreditation Cooperation (ILAC). ILAC G-2:1994. Available from: http://www.ilac.org. Accessed November 2004.Suche in Google Scholar

5. Guide to the expression of uncertainty in measurement. Geneva: International Organization for Standardization (ISO), 1993.Suche in Google Scholar

6. ISO 17025: General requirements for the competence of testing and calibration laboratories. Geneva: International Organization for Standardization (ISO), 2005.Suche in Google Scholar

7. ISO 15189: Medical laboratories – particular requirements for quality and competence. Geneva: International Organization for Standardization (ISO), 2012.Suche in Google Scholar

8. Evaluation of measurement data – Guide to the expression of uncertainty in measurement. JCGM 100:2008.Suche in Google Scholar

9. Measurement uncertainty revisited: alternative approaches to uncertainty evaluation. European Federation of National Associations of Measurement, Testing and Analytical Laboratories, EUROLAB. Technical Report No. 1/2007.Suche in Google Scholar

10. SH GTA 14: Technical guide for accreditation for the uncertainty measurement assessment in medical biology. Available from: http://www.cofrac.fr. Accessed 2011.Suche in Google Scholar

11. Meijer P, de Maat MP, Kluft C, Haverkate F, van Houwelingen HC. Long-term analytical performance of hemostasis field methods as assessed by evaluation of the results of an external quality assessment program for antithrombin. Clin Chem 2002;48:1011–5.10.1093/clinchem/48.7.1011Suche in Google Scholar

12. ISO 13528: Statistical methods for use in proficiency testing by interlaboratory comparisons. Geneva: International Organization for Standardization (ISO), 2005.Suche in Google Scholar

13. ISO 17043: Conformity assessment – general requirements for proficiency testing. Geneva: International Organization for Standardization (ISO), 2010.Suche in Google Scholar

14. Fisicaro P, Amarouche S, Lalere B, Labarraque G, Priel M. Approaches to uncertainty evaluation based on proficiency testing schemes in chemical measurements. Accred Qual Assur 2008;13:361–6.10.1007/s00769-008-0402-xSuche in Google Scholar

15. Amarouche, S, Priel M, De Graeve J. Exploiting proficiency testing results, a new alternative to the evaluation of uncertainties: application in medical biology: dosage of glucose in human plasma. Workshop on the Impact of Information Technology in Metrology. BIPM-PTB, Berlin, 2007.Suche in Google Scholar

16. SH GTA 06: Technical guide for accreditation: quality assessment in medical biology. Available from: http://www.cofrac.fr. Accessed 2012.Suche in Google Scholar

17. Vassault A, Grafmeyer D, de Graeve J, Cohen R, Beaudonnet A, Bienvenu J. Analyses de biologie médicale: spécifications et normes d’acceptabilité à l’usage de la validation de techniques. Ann Biol Clin 1999;57:685–95.Suche in Google Scholar

18. Miller WG, Jones GR, Horowitz GL, Weykamp C. Proficiency testing/external quality assessment: current challenges and future directions. Clin Chem 2011;57:1670–80.10.1373/clinchem.2011.168641Suche in Google Scholar PubMed

19. CLSI. Characterization and qualification of commutable reference materials for laboratory medicine; CLSI document EP30-A. Wayne, PA: Clinical and Laboratory Standards Institute, 2010.Suche in Google Scholar

Received: 2014-9-24
Accepted: 2015-2-19
Published Online: 2015-3-26
Published in Print: 2015-10-1

©2015 by De Gruyter

Artikel in diesem Heft

  1. Frontmatter
  2. Editorials
  3. Laboratory medicine does matter in science (and medicine)… yet many seem to ignore it
  4. The standardization of the urine albumin assays: no longer deferrable
  5. Reviews
  6. The role of telomeres and vitamin D in cellular aging and age-related diseases
  7. Atypical hemolytic uremic syndrome: from diagnosis to treatment
  8. Clinical relevance and contemporary methods for counting blood cells in body fluids suspected of inflammatory disease
  9. EFLM Opinion Paper
  10. How to assess the quality of your analytical method?
  11. Genetics and Molecular Diagnostics
  12. Validation of CFTR intronic variants identified during cystic fibrosis population screening by a minigene splicing assay
  13. General Clinical Chemistry and Laboratory Medicine
  14. Uncertainty in measurement for 43 biochemistry, immunoassay, and hemostasis routine analytes evaluated by a method using only external quality assessment data
  15. A study examining the bias of albumin and albumin/creatinine ratio measurements in urine
  16. National survey on appropriateness of clinical biochemistry reporting in China
  17. Potentiometric measurement of urinary iodine concentration in patients with thyroid diseases with and without previous exposure to non-radioactive iodine
  18. Determination of 21-hydroxylase autoantibodies: inter-laboratory concordance in the Euradrenal International Serum Exchange Program
  19. Value of a commercial kit for detecting anti-C1q autoantibodies and correlation with immunological and clinical activity of lupus nephritis
  20. Comparison of the bead-based simultaneous analysis of specific platelet antibodies assay (SASPA) and Pak Lx Luminex technology with the monoclonal antibody immobilization of platelet antigens assay (MAIPA) to detect platelet alloantibodies
  21. Measurement of the inflammatory response in the early postoperative period after hip and knee arthroplasty
  22. Whole blood thromboelastometry profiles in women with preeclampsia
  23. Increased plasma soluble urokinase plasminogen activator receptor levels in systemic sclerosis: possible association with microvascular abnormalities and extent of fibrosis
  24. Reference Values and Biological Variations
  25. Reference ranges of serum bile acids in children and adolescents
  26. Infectious Diseases
  27. Elevated circulating ghrelin, but not peptide YY(3-36) levels, in term neonates with infection
  28. Cardiovascular Diseases
  29. Head-to-head comparison of 10 natriuretic peptide assays
  30. Prognostic role of BNP in children undergoing surgery for congenital heart disease: analysis of prediction models incorporating standard risk factors
  31. Elevations of inflammatory markers PTX3 and sST2 after resuscitation from cardiac arrest are associated with multiple organ dysfunction syndrome and early death
  32. Identification of molecular species of oxidized triglyceride in plasma and its distribution in lipoproteins
  33. A new formula for estimation of low-density lipoprotein cholesterol in an ethnic Chinese population
  34. Letter to the Editors
  35. Laboratory medicine: let’s say it is the mirror of science (and medicine)
  36. The economic burden of hemolysis
  37. Acute effects of conventional and extended hemodialysis and hemodiafiltration on high-sensitivity cardiac troponins
  38. Cuvette carryover with the gentamicin assay on the Beckman AU480 analyser
  39. Comparison study of two commercially available methods for the determination of golimumab and anti-golimumab antibody levels in patients with rheumatic diseases
  40. Automated alkaline-pH electrophoresis followed by densitometry does not correlate with cation-exchange (CE)-HPLC in quantification of HbA2 and variant hemoglobins
  41. Progression from light chain myeloma to secondary plasma cell leukemia accompanied by peripheral blood eosinophilia
  42. Harmonization of results has not been fully achieved for serum immunoglobulin measurements
  43. The risk of macrovascular complications in subjects genotyped for common IL-6 gene and TNF-α gene variants
  44. Comparison of nucleated red blood cell count with four commercial hematological analyzers
  45. Reply to: The risk of macrovascular complications in subjects genotyped for common IL-6 gene and TNF-α gene variants
  46. Congress Abstracts
  47. Congress of Clinical Chemistry and Laboratory Medicine
  48. 47th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC – Laboratory Medicine)
  49. 15th EFLM Continuous Postgraduate Course in Clinical Chemistry and Laboratory Medicine
Heruntergeladen am 7.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2014-0942/html
Button zum nach oben scrollen